$RADIOPHARM THERANOSTICS LIMITED SPON ADR EACH REP 300 ORD(RADX)$
The press release detailing the positive interim results for the RAD 101 Phase 2b trial was released 5 hours ago from the current time.
Based on the information, the release time was:
• 3:00 AM EST (Eastern Standard Time) on Monday, December 15, 2025.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
